| タイトル | Sunitinib inhibits RNase L by destabilizing its active dimer conformation. |
|---|
| ジャーナル・号・ページ | Biochem. J., Vol. 477, Page 3387-3399, Year 2020 |
|---|
| 掲載日 | 2020年2月24日 (構造データの登録日) |
|---|
著者 | Tang, J. / Wang, Y. / Zhou, H. / Ye, Y. / Talukdar, M. / Fu, Z. / Liu, Z. / Li, J. / Neculai, D. / Gao, J. / Huang, H. |
|---|
リンク | Biochem. J. / PubMed:32830849 |
|---|
| 手法 | X線回折 |
|---|
| 解像度 | 2.4 - 2.56 Å |
|---|
| 構造データ | PDB-6m11: Crystal structure of Rnase L in complex with Sunitinib 手法: X-RAY DIFFRACTION / 解像度: 2.46 Å PDB-6m12: Crystal Structure of Rnase L in complex with SU11652 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-6m13: Crystal structure of Rnase L in complex with Toceranib 手法: X-RAY DIFFRACTION / 解像度: 2.56 Å |
|---|
| 化合物 | ChemComp-B49: N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbo / スニチニブ / 薬剤, 抗がん剤, 阻害剤*YM
ChemComp-J60: 5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE / SU-11652
ChemComp-25L: [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate / 2′-O-[2′-O-(5′-アデニリル)-5′-アデニリル]アデノシン5′-三りん酸
ChemComp-BWC: 5-[(Z)-(5-fluoranyl-2-oxidanylidene-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide / トセラニブ
|
|---|
| 由来 |  sus scrofa (ブタ)
|
|---|
キーワード | HYDROLASE / Inhibitor / Complex / RNase L / Sunitinib / SU11652 / Kinase / Toceranib |
|---|